Drug Trial Radar · NCT00550992
Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia
Last checked: Nov 20, 2026Latest source record: Jul 30, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
445
Planned (sponsor's estimate)
Start
Jan 2006
Primary completion
Dec 2020
Sponsor
- Lead sponsor
- Dutch Childhood Oncology GroupAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- BFM Germany; CORS Monza Italy; Associazione Italiana Ematologia Oncologia Pediatrica; Australian and New Zealand Children's Oncology Group; BFM Austria; CLCG France Belgium Portugal; COALL Germany; CPH, Czech republic; DFCI consortium USA; FRALLE France; Hong Kong Government; MD Anderson USA; NOPHO Scandinavian countries; PINDA, Chile; PPLLSG Poland; Seattle USA; SJCRH USA; UKCCSG United Kingdom
- First posted
- Oct 30, 2007
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, up to 1 year
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Giving chemotherapy before a donor stem cell transplant helps stop the growth of cancer cells. It also helps stop the patient's immune system from rejecting the donor's stem cells. When the healthy stem cells from a donor are infused into the patient they may help the patient's bone marrow make stem cells, red blood cells, white blood cells, and platelets. Sometimes the transplanted cells from a donor can make an immune response against the body's normal cells. Giving cyclosporine, methotrexate, leucovorin, and antithymocyte globulin before and after transplant may stop this from happening. It is not yet known which treatment regimen is most effective in treating acute leukemia. PURPOSE: This randomized clinical trial is studying how well different therapies work in treating infants with newly diagnosed acute leukemia.
Conditions
- Leukemia
Interventions
anti-thymocyte globulinBiological
asparaginaseDrug
busulfanDrug
cyclophosphamideDrug
cyclosporineDrug
cytarabineDrug
daunorubicin hydrochlorideDrug
etoposideDrug
leucovorin calciumDrug
melphalanDrug
mercaptopurineDrug
methotrexateDrug
mitoxantrone hydrochlorideDrug
pegaspargaseDrug
prednisoloneDrug
prednisoneDrug
therapeutic hydrocortisoneDrug
thioguanineDrug
vincristine sulfateDrug
allogeneic bone marrow transplantationProcedure
allogeneic hematopoietic stem cell transplantationProcedure
umbilical cord blood transplantationProcedure
Primary outcomes
What the sponsor says the trial is designed to measure.
- Disease-free survival
Locations
13 sites in 9 countries. Site status is shown where the registry gives one.
Children's Hospital Boston
Boston, Massachusetts · Recruiting
St. Jude Children's Research Hospital
Memphis, Tennessee · Recruiting
M. D. Anderson Cancer Center at University of Texas
Houston, Texas · Recruiting
Children's Hospital and Regional Medical Center - Seattle
Seattle, Washington · Recruiting
St. Anna Children's Hospital
Vienna, Austria · Recruiting
Hopital Universitaire Des Enfants Reine Fabiola
Brussels, Belgium · Recruiting
University Hospital Motol
Prague, Czechia · Recruiting
CHR Hotel Dieu
Nantes, France · Recruiting
University Medical Center Hamburg - Eppendorf
Hamburg, Germany · Recruiting
Medizinische Hochschule Hannover
Hanover, Germany · Recruiting
Nuovo Ospedale San Gerardo at University of Milano-Bicocca
Monza, Italy · Recruiting
Erasmus MC - Sophia Children's Hospital
Rotterdam, Netherlands · Recruiting
Great Ormond Street Hospital for Children
London, England, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.